Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    October 2022
  1. CAMILLERI M, Boeckxstaens G
    Irritable bowel syndrome: treatment based on pathophysiology and biomarkers.
    Gut. 2022 Oct 28. pii: gutjnl-2022-328515. doi: 10.1136/gutjnl-2022-328515.
    PubMed     Abstract available


  2. PETITFILS C, Maurel S, Payros G, Hueber A, et al
    Identification of bacterial lipopeptides as key players in IBS.
    Gut. 2022 Oct 14. pii: gutjnl-2022-328084. doi: 10.1136/gutjnl-2022-328084.
    PubMed     Abstract available


  3. TACK J, Van den Houte K, Carbone F
    Role of the DOMINO diet application for managing IBS in primary care and beyond.
    Gut. 2022 Oct 13. pii: gutjnl-2022-328315. doi: 10.1136/gutjnl-2022-328315.
    PubMed    


    September 2022
  4. JALANKA J, Gunn D, Singh G, Krishnasamy S, et al
    Postinfective bowel dysfunction following Campylobacter enteritis is characterised by reduced microbiota diversity and impaired microbiota recovery.
    Gut. 2022 Sep 28. pii: gutjnl-2021-326828. doi: 10.1136/gutjnl-2021-326828.
    PubMed     Abstract available


  5. BALSIGER LM, Van den Houte K, Zheng T, Toth J, et al
    Genetic analyses of treatment response in primary care IBS, a pilot study.
    Gut. 2022 Sep 23. pii: gutjnl-2022-328430. doi: 10.1136/gutjnl-2022-328430.
    PubMed    


    July 2022
  6. CAMILLERI M
    Fifty-point IBS-SSS responders but persistence of moderate severity IBS in over 40% of those on diet.
    Gut. 2022 Jul 26. pii: gutjnl-2022-328211. doi: 10.1136/gutjnl-2022-328211.
    PubMed    


    June 2022
  7. HOWELL CA, Kemppinen A, Allgar V, Dodd M, et al
    Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D).
    Gut. 2022 Jun 27. pii: gutjnl-2022-327293. doi: 10.1136/gutjnl-2022-327293.
    PubMed     Abstract available


  8. REJ A, Sanders DS, Aziz I
    Further research needed to determine first-line therapy for IBS in primary care.
    Gut. 2022 Jun 22. pii: gutjnl-2022-328047. doi: 10.1136/gutjnl-2022-328047.
    PubMed    


    May 2022
  9. CAMILLERI M, Carlson P, BouSaba J, McKinzie S, et al
    Comparison of biochemical, microbial and mucosal mRNA expression in bile acid diarrhoea and irritable bowel syndrome with diarrhoea.
    Gut. 2022 May 17. pii: gutjnl-2022-327471. doi: 10.1136/gutjnl-2022-327471.
    PubMed     Abstract available


    April 2022
  10. CARBONE F, Van den Houte K, Besard L, Tack C, et al
    Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian Health Care Knowledge Centre (KCE Trials Programme) and the Rome Foundation Research Institute.
    Gut. 2022 Apr 28. pii: gutjnl-2021-325821. doi: 10.1136/gutjnl-2021-325821.
    PubMed     Abstract available


    November 2021
  11. VERVIER K, Moss S, Kumar N, Adoum A, et al
    Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet.
    Gut. 2021 Nov 22. pii: gutjnl-2021-325177. doi: 10.1136/gutjnl-2021-325177.
    PubMed     Abstract available


  12. GIBSON PR, Halmos EP
    The FODMAP diet: more than just a symptomatic therapy?
    Gut. 2021 Nov 22. pii: gutjnl-2021-326284. doi: 10.1136/gutjnl-2021-326284.
    PubMed    


  13. BALSIGER LM, Tack J
    Letter to the editor: prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome.
    Gut. 2021 Nov 10. pii: gutjnl-2021-326252. doi: 10.1136/gutjnl-2021-326252.
    PubMed    


    October 2021
  14. FOLEY A, Halmos EP, Husein DM, Fehily SR, et al
    Adult sucrase-isomaltase deficiency masquerading as IBS.
    Gut. 2021 Oct 6. pii: gutjnl-2021-326153. doi: 10.1136/gutjnl-2021-326153.
    PubMed    


    September 2021
  15. VERBEKE K
    Combining dietary fibres to reduce intestinal gas production in patients with IBS.
    Gut. 2021 Sep 23. pii: gutjnl-2021-325618. doi: 10.1136/gutjnl-2021-325618.
    PubMed    


  16. BOJARSKI C, Tangermann P, Barmeyer C, Buchkremer J, et al
    Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome.
    Gut. 2021 Sep 20. pii: gutjnl-2021-325181. doi: 10.1136/gutjnl-2021-325181.
    PubMed     Abstract available


    August 2021
  17. SO D, Gibson PR, Muir JG, Yao CK, et al
    Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine.
    Gut. 2021 Aug 20. pii: gutjnl-2021-324891. doi: 10.1136/gutjnl-2021-324891.
    PubMed     Abstract available


  18. BLACK CJ, Staudacher HM, Ford AC
    Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.
    Gut. 2021 Aug 10. pii: gutjnl-2021-325214. doi: 10.1136/gutjnl-2021-325214.
    PubMed     Abstract available


  19. GUNN D, Abbas Z, Harris HC, Major G, et al
    Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies.
    Gut. 2021 Aug 5. pii: gutjnl-2021-324784. doi: 10.1136/gutjnl-2021-324784.
    PubMed     Abstract available


    April 2021
  20. VASANT DH, Paine PA, Black CJ, Houghton LA, et al
    British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.
    Gut. 2021 Apr 26. pii: gutjnl-2021-324598. doi: 10.1136/gutjnl-2021-324598.
    PubMed     Abstract available


  21. BOLTE LA, Vich Vila A, Imhann F, Collij V, et al
    Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome.
    Gut. 2021 Apr 2. pii: gutjnl-2020-322670. doi: 10.1136/gutjnl-2020-322670.
    PubMed     Abstract available


    March 2021
  22. EL-SALHY M
    FMT in IBS: how cautious should we be?
    Gut. 2021;70:626-628.
    PubMed    


    February 2021
  23. CAMILLERI M
    FMT in IBS: a call for caution.
    Gut. 2021;70:431.
    PubMed    


    December 2020
  24. SPILLER RC, Jalanka J
    Brachyspira and IBS with diarrhoea: a Helicobacter pylori moment?
    Gut. 2020 Dec 24. pii: gutjnl-2020-323370. doi: 10.1136/gutjnl-2020-323370.
    PubMed    


    November 2020
  25. JABBAR KS, Dolan B, Eklund L, Wising C, et al
    Association between Brachyspira and irritable bowel syndrome with diarrhoea.
    Gut. 2020 Nov 11. pii: gutjnl-2020-321466. doi: 10.1136/gutjnl-2020-321466.
    PubMed     Abstract available


    October 2020
  26. MASSIER L, Chakaroun R, Kovacs P, Heiker JT, et al
    Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability.
    Gut. 2020 Oct 9. pii: gutjnl-2020-323026. doi: 10.1136/gutjnl-2020-323026.
    PubMed    


  27. PERNA E, Aguilera-Lizarraga J, Florens MV, Jain P, et al
    Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS.
    Gut. 2020 Oct 6. pii: gutjnl-2020-321530. doi: 10.1136/gutjnl-2020-321530.
    PubMed     Abstract available


    September 2020
  28. BLACK CJ, Craig O, Gracie DJ, Ford AC, et al
    Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Gut. 2020 Sep 24. pii: gutjnl-2020-322519. doi: 10.1136/gutjnl-2020-322519.
    PubMed     Abstract available


    May 2020
  29. REJ A, Buckle RL, Shaw CC, Trott N, et al
    Is CBT the dominant non-drug IBS treatment? The rise of dietary therapies.
    Gut. 2020 May 19. pii: gutjnl-2020-321658. doi: 10.1136/gutjnl-2020-321658.
    PubMed    


  30. POTTER MDE, Goodsall TM, Walker MM, Talley NJ, et al
    Dual histamine blockade for the treatment of adult functional dyspepsia: a single centre experience.
    Gut. 2020;69:966.
    PubMed    


    April 2020
  31. BLACK CJ, Thakur ER, Houghton LA, Quigley EMM, et al
    Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis.
    Gut. 2020 Apr 10. pii: gutjnl-2020-321191. doi: 10.1136/gutjnl-2020-321191.
    PubMed     Abstract available


    March 2020
  32. JEFFERY IB, O'Herlihy E, Shanahan F, O' Toole PW, et al
    Microbiome alterations in IBS.
    Gut. 2020 Mar 5. pii: gutjnl-2020-320919. doi: 10.1136/gutjnl-2020-320919.
    PubMed    


    February 2020
  33. BARBARA G, Ianiro G
    Faecal microbial transplantation in IBS: ready for prime time?
    Gut. 2020 Feb 26. pii: gutjnl-2019-320411. doi: 10.1136/gutjnl-2019-320411.
    PubMed    


  34. BARBARO MR, Cremon C, Morselli-Labate AM, Di Sabatino A, et al
    Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity.
    Gut. 2020 Feb 14. pii: gutjnl-2019-319281. doi: 10.1136/gutjnl-2019-319281.
    PubMed     Abstract available


    January 2020
  35. BLACK CJ, Burr NE, Camilleri M, Earnest DL, et al
    Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
    Gut. 2020;69:74-82.
    PubMed     Abstract available


  36. EDOGAWA S, Edwinson AL, Peters SA, Chikkamenahalli LL, et al
    Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
    Gut. 2020;69:62-73.
    PubMed     Abstract available


    December 2019
  37. EL-SALHY M, Hatlebakk JG, Gilja OH, Brathen Kristoffersen A, et al
    Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
    Gut. 2019 Dec 18. pii: gutjnl-2019-319630. doi: 10.1136/gutjnl-2019-319630.
    PubMed     Abstract available


  38. LIU H, Han M, Li SC, Tan G, et al
    Resilience of human gut microbial communities for the long stay with multiple dietary shifts.
    Gut. 2019;68:2254-2255.
    PubMed    


    November 2019
  39. ONG J, Swift C, Allwood I, Norman R, et al
    Chronic diarrhoea: the indications for lower GI endoscopy when functional bowel disease is suspected.
    Gut. 2019;68:2100.
    PubMed    


    October 2019
  40. HUGERTH LW, Andreasson A, Talley NJ, Forsberg AM, et al
    No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.
    Gut. 2019 Oct 10. pii: gutjnl-2019-318717. doi: 10.1136/gutjnl-2019-318717.
    PubMed     Abstract available


    September 2019
  41. TALLEY NJ, Holtmann GJ, Jones M, Koloski NA, et al
    Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity.
    Gut. 2019 Sep 28. pii: gutjnl-2019-318664. doi: 10.1136/gutjnl-2019-318664.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: